Cell Therapy News ✓

@celltherapynews · joined 19 Mar 2009

An online resource for the latest cell therapy, gene therapy and regenerative medicine news. Part of the @STEMCELLTech Science News service.

12 335Followers

603Following

15 008Posts total

5.8KViews on collected posts

Latest posts

Cell Therapy News ✓@celltherapynews8 Sep

The industry’s only summit dedicated to raw materials in Cell & Gene Therapy (CGT) is back! Join CGT leaders this October in San Diego to tackle raw material risk, prevent delays, strengthen supplier strategies, and scale toward commercialization. 🔗 https://t.co/hdJZ5DRcgr ht

362 views · 2 likes · 2 reposts · 0 replies Open on X →

Cell Therapy News ✓@celltherapynews7 Sep

Researchers underscored the functional relevance of Y218 phosphorylation in modulating #CARTcell fate and reveal a strategy to fine-tune CAR signaling through targeted kinase recruitment to enhance therapeutic efficacy. 🧬 Learn more: https://t.co/jDSrWXx2ee https://t.co/XBb8h6qZ

414 views · 6 likes · 1 reposts · 0 replies Open on X →

Cell Therapy News ✓@celltherapynews4 Sep

This #OpenAccess study in @LeukemiaJnl shows that CAR structure is a critical determinant of CD19 loss in tumor B cells. 💡 https://t.co/4zXwsZj2D5 Repeated exposure to CD19–4-1BB-based CAR-T cells, but not CD19–CD28-based counterparts, drives FMC63-epitope and total CD19 https:/

585 views · 5 likes · 0 reposts · 0 replies Open on X →

Cell Therapy News ✓@celltherapynews3 Sep

Scientists with Elena Martinez-Planes at @MoffittNews identified tyrosine 218 (Y218) in the CD28 cytoplasmic domain as a critical regulatory site, and demonstrate that its phosphorylation is essential for optimal CAR-T cell activity. 📝 https://t.co/jDSrWXx2ee https://t.co/x3OTz

4.1K views · 11 likes · 2 reposts · 0 replies Open on X →

Cell Therapy News ✓@celltherapynews24 Aug

The Science News Program by @STEMCELLTech offers 20 free newsletters in various fields of cell biology, and allows you to easily personalize your subscriptions. Visit today to get started! 👇 https://t.co/eTMNwsDTkw https://t.co/kpHBehn3rZ

396 views · 1 likes · 0 reposts · 0 replies Open on X →

Against accounts of the same size

5 posts from the last 90 days, next to the 10K–100K follower range. ordinary reach for its size, weaker reaction than most.

Median views414this account924median for 10K–100K

Reach, %3.36%this account3.62%median for 10K–100K

Engagement, %0.85%this account1.52%median for 10K–100K

Metric	This account	Median for 10K–100K	Ratio
Median views per post	414	924	0.45×
Reach (views ÷ followers)	3.36%	3.62%	0.93×
Engagement rate	0.85%	1.52%	0.56×

Others in this range → Compare with another account → How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

39624 Aug

4.1K3 Sep

5854 Sep

4147 Sep

3628 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.25%24 Aug

0.32%3 Sep

0.85%4 Sep

1.69%7 Sep

1.10%8 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes69.4%25 in total

Reposts13.9%5 in total

Bookmarks16.7%6 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.